Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCR7 (C-C chemokine receptor type 7), also known as CD197, is a G protein-coupled receptor (GPCR) that binds to the chemokines CCL19 and CCL21. It plays a crucial role in immune cell trafficking to secondary lymphoid organs and is involved in both anti-tumor immunity and cancer metastasis. Due to its complex roles, therapeutic targeting of CCR7 requires careful consideration of the specific disease context.
Agonism or antagonism of CCR7 signaling (context-dependent)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine ligand 21 receptor (CCR7).